Jonathan Sheena - May 10, 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
May 10, 2024
Transactions value $
-$283,794
Form type
4
Date filed
5/10/2024, 09:35 PM
Previous filing
Apr 26, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$36K -349 -0.11% $103.06 321K May 10, 2024 Direct F1, F2, F3
transaction NTRA Common Stock Sale -$104K -990 -0.31% $104.60 320K May 10, 2024 Direct F1, F4
transaction NTRA Common Stock Sale -$69.6K -660 -0.21% $105.51 320K May 10, 2024 Direct F1, F5
transaction NTRA Common Stock Sale -$65K -611 -0.19% $106.32 319K May 10, 2024 Direct F1, F6
transaction NTRA Common Stock Sale -$9.67K -90 -0.03% $107.48 319K May 10, 2024 Direct F1
holding NTRA Common Stock 69.1K May 10, 2024 By Caraluna 1 Trust F7
holding NTRA Common Stock 69.1K May 10, 2024 By Caraluna 2 Trust F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.87 to $103.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 397 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on April 29, 2024.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.99 to $104.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.16 to $106.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.